The Team of FluoSphera explains our technology and how it can reduce animal experimentation in a video interview!
JULY 26, 2022
The ultimate goal of alternatives to animal experimentation is not simply to provide models as relevant as animals, but much better! This is the best way to develop more potent and safer therapies for patients!
In this video (with also a teaser) made by LSCV, the team of FluoSphera explains how our technology is used as a powerful alternative to animal experimentation for drug discovery and for toxicity testing.
FluoSphera will be at the Swiss Biotech Day!
MAY 2, 2022
FluoSphera hired an R&D Technician!
MAY 2, 2022
FluoSphera hired an R&D technician to strengthen R&D on new biosystems!
FluoSphera will be at the SACHS Life Sciences CEO Forum!
MARCH 1, 2022
SACHS Associates Life Sciences CEO Forum is an excellent event to meet with investors in the life sciences sector. FluoSphera will be presenting its technology as a unique opportunity to improve the quality of drugs for the patients, to reduce the costs of drug development failure, and to reduce animal experimentation.
FluoSphera was listed among Swiss companies providing alternatives to animal experimentation!
FEBRUARY 17, 2022
FluoSphera, speaker at the first event of the year at the Fongit!
JANUARY 24, 2022
FluoSphera is now a company of the Fongit!
JANUARY 7, 2022
FluoSphera obtained a grant from Fongit Innovation fund!
AUGUST 8, 2021
Dr. Marie Shamseddin is the new CTO of FluoSphera!
AUGUST 1, 2021
FluoSphera is delighted to welcome Dr. Marie Shamseddin as the new Chief Technology Officer. Marie performed a career of life scientist in world-renowned Institutes. After a Ph.D. in Molecular Life Sciences at the EPFL, she did a post-doctoral training at the Wellcome Sanger Institute and at the Cambridge Institute for Medical Research. Thanks to her expertise, Marie will bring the technology of FluoSphera to the next level!
FluoSphera got an Innogap grant!
JUNE 30, 2021
Unitec Technology Transfer Office will support FluoSphera with an Innogap grant of CHF 30’000 for the development of a new product to predict the cardiotoxicity of compounds in the presence of hepatic metabolism! Very grateful for that!
FluoSphera hires a CHIEF TECHNOLOGY OFFICER!
FEBRUARY 9, 2021
FluoSphera hires a Chief Technology Officer (CTO) to develop further the technology of multi-tissue test system (proof-of-concept, prototyping, large-scale validation) and to strengthen the leadership team.
FluoSphera, winner of the pitch competition organised during the Start-up Day 2021 of Toulouse White Biotechnologies!
FEBRUARY 3, 2021
Every year, Toulouse White Biotechnologies (TWB) organises a start-up day to gather biotech players involved in a sustainable economy with a positive impact on environment. FluoSphera won the pitch competition “Go for it” , a specific track for pre-seed stage start-ups.
A virtual booth for FluoSphera at the Swiss Startup Accelerator Showcase 2020!
DECEMBER 3, 2020
FluoSphera and other Geneus innovators participated in the Swiss Startup Accelerator Showcase 2020, organized by Innopeaks and La Forge (EPFL Innovation Park) startup accelerators. In a 3D model of the Swiss Convention centre, a virtual booth was created for each of the 30 startups participating in the pitch competition.
FluoSphera was the Winner of the Environment track and Grand Finalist of the iGEM Startup Showcase 2020!
NOVEMBER 20, 2020
After being selected among more than 100 iGEM startups, FluoSphera won the pitch competition in the Environment track against 4 other startups, and was selected in the Top 3 startups for the Grand Finale of the iGEM Startup Showcase 2020.
FluoSphera joins the Bench2biz program, one of the best Startup Training in Switzerland.
NOVEMBER 13, 2020
FluoSphera selected for the semi-finals of the iGEM Startup Showcase 2020.
NOVEMBER 12, 2020
FluoSphera has been selected in the Top 5 of the Environment Track for the semi-finals of the iGEM Startup Showcase 2020. This event will be organized by iGEM EPIC on November 20, 2020 to highlight the top iGEM Biofounders and to win an interview with the Y Combinator.
A financial support from Innosuisse to FluoSphera for the Proof-of-Concept and the Prototyping of our future assays
OCTOBER 16, 2020
FluoSphera benefits now from Innosuisse Initial Coaching
AUGUST 6, 2020
Gregory Segala, CEO of FluoSphera, invited at the Medical Research Center of Geneva (CMU) to give a seminar on the 3Rs
FEBRUARY 26, 2020
Gregory Segala will present the last alternative methods to animal experimentation. He will also take the opportunity to speak about the potential of FluoSphera to reduce animal experimentation.
FluoSphera won the Prize of the Best Idea in Life Sciences for the GEW Geneva 2019
NOVEMBER 22, 2019
During the Global Entrepreneurship Week (GEW) organized in Geneva, FluoSphera was selected as the Best Idea in Life Sciences by a jury of business and industry experts as well as experienced entrepreneurs.
FluoSphera won the Prize Innosciences to join the Science Innovation Hub!
NOVEMBER 8, 2019
For the inauguration of the Science Innovation Hub, FluoSphera was the recipient of the Prize Innosciences and will be hosted at the Faculty of Sciences of the University of Geneva (also hosting two Nobel Prize winners the same year!).
iGEM Geneva 2019 won a Silver Medal for the project FluoSphera at the iGEM Giant Jamboree in Boston
NOVEMBER 6, 2019
For the first participation of the University of Geneva in the iGEM (international Genetically Engineered Machine), the worldwide competition in synthetic biology, we won the Silver Medal for our project FluoSphera.
Release of the website on the project FluoSphera from iGEM Geneva 2019
OCTOBER 22, 2019